What is the maximum recommended dose of metoclopramide for adults and children?

Maximum Dose of Metoclopramide

For adults with gastroparesis, the maximum oral dose is 10 mg before meals (three times daily), and for intranasal formulation, 15 mg before meals and at bedtime. 1

Adult Dosing by Indication

Gastroparesis (Oral/Intranasal)

• Oral formulation: Start with 5 mg before meals, titrate up to maximum of 10 mg before meals (three times daily) 1
• Intranasal formulation: 15 mg before meals and at bedtime 1
• Total maximum daily dose: 30-40 mg/day for oral; 60 mg/day for intranasal

Chemotherapy-Induced Nausea/Vomiting (IV)

• High emetogenic chemotherapy: 2 mg/kg per dose IV over 15 minutes, given 30 minutes before chemotherapy, then every 2 hours for two doses, then every 3 hours for three doses 2
• Less emetogenic regimens: 1 mg/kg per dose may be adequate 2
• This represents significantly higher dosing than gastroparesis treatment

Other Indications (Lower Doses)

• Postoperative nausea/vomiting: 10-20 mg IM/IV 2
• Breakthrough nausea (cancer pain): 10-20 mg PO/IV every 4-6 hours 3
• Opioid-induced nausea: 10-20 mg PO multiple times daily 3

Pediatric Dosing

Gastroparesis/General Use

• Not well-established for gastroparesis specifically in children
• Population pharmacokinetic modeling suggests 0.1 mg/kg every 6 hours for gastroesophageal reflux 4

Chemotherapy-Induced Nausea (IV)

• Initial studies: 2 mg/kg per dose, but associated with 15% extrapyramidal reactions and 33% akathisia 5
• Dose reduction recommended: 1 mg/kg per dose to reduce adverse effects 5, 6
• Age-related risk: Children <30 years have 25% or higher incidence of extrapyramidal symptoms at 2 mg/kg dosing 5

Small Bowel Intubation

• Age >14 years: 10 mg IV 2
• Age 6-14 years: 2.5-5 mg IV 2
• Age <6 years: 0.1 mg/kg IV 2

Critical Safety Considerations

FDA Black Box Warning

The FDA issued a black box warning regarding tardive dyskinesia risk 1. This risk increases with:

• Duration of treatment beyond 12 weeks
• Higher cumulative doses
• Older age
• Female gender

European Medicines Agency Restrictions

The EMA has restricted metoclopramide to 7:

• Maximum 30 mg/day in adults
• Maximum 5 days duration to minimize neurological side-effects
• Contraindicated in children <1 year
• Caution in children <5 years

Dose Reduction in Renal Impairment

For creatinine clearance <40 mL/min: initiate at approximately one-half the recommended dosage, then titrate based on efficacy and safety 2

Extrapyramidal Symptom Management

If acute dystonic reactions occur: Inject 50 mg diphenhydramine IM; symptoms usually subside rapidly 2, 5, 6

Prophylaxis in high-risk patients: Consider concurrent diphenhydramine, especially in:

• Pediatric patients
• Adults <30 years receiving high-dose metoclopramide
• Patients receiving consecutive days of treatment 5, 6

Practical Dosing Strategy for Gastroparesis

1. Start low: 5 mg PO before meals 1
2. Titrate gradually to 10 mg before meals based on symptom response
3. Assess at 4-8 weeks for efficacy and adverse effects (including movement disorders) 1
4. Consider drug holidays: 1-4 weeks off every 8-12 weeks to improve tolerability and reduce tardive dyskinesia risk 1
5. Maximum duration: Avoid chronic use beyond what is necessary; reassess regularly

Common Pitfall

Do not exceed 10 mg per dose orally for gastroparesis in routine clinical practice. The much higher doses (1-2 mg/kg IV) used in chemotherapy-induced nausea are reserved for that specific indication and carry substantially higher risk of extrapyramidal symptoms, particularly in younger patients 5, 8.